From: Exploring plant-based dengue therapeutics: from laboratory to clinic
Plant | Part used | Family | Potential Phytocompounds | Dose | Mode of action/Target protein | Reference |
---|---|---|---|---|---|---|
Alternanthera photoperiods | WP | Amaranthaceae | Hexamethyl-3,3-bis[trimethylsilyl) oxy]trisiloxane, S,S-dioxide trans-2-methyl-4-Npentylthiane, didodecylphthalate | 47.43 μg/ml | Inhibition of virus | [57] |
Andrographis paniculata | Leaves | Flaviviridae | Diterpenoids, flavonoids and polyphenols | 500 μg | Decrease in viral load | [97] |
Acorus calamus | Leaves | Acoracea | Artesunic acid | - | NS5 | [101] |
Cladogynos orientalis | WP | Euphorbiaceae | Chlorogenic acid, catechin, epicechin, caffeic acid, vanilla acid, coumaric acid, quercetin, rutin | 12.5 μg/ml-100 μg/ml | Inactivated viral particles | [62] |
Euphorbia hirta | WP | Euphorbiaceae | Triterpene and flavonoids | 100 μg/ml | Reduced DENV-2 plaque | [114] |
Flagellaria indica | WP | Flagellariaceae | Flavonoids, tannins, saponins, steroids, triterpenoids, alkaloids | 312 μg/ml | Inactivated viral particles | [62] |
Flacourtia ramontchi | Stem, barks | Salicaceae | Betulinic acid 3β-caffeate, flacourtosides A and E (1 and 5), scolochinenoside D | 0.85 µM | Inhibits RNA polymerase | [26] |
Faramea bahinensis | Leaves | Rubiaceae | Flavone glycoside | 100-200 μg/ml | Viral replication inhibition | [84] |
Faramea bahinensis | Leaves | Rubiaceae | Phenolics, flavonoids | 50 μg/ml | Reduced viral load | [127] |
Hippophae rhamnoides | Leaves | Elaeagnaceae | Carotenoids, tocopherols, sterols, flavonoids, lipids, ascorbic acid. tannins | 50 μg/ml | Reduction in TNF-α and plaque | [55] |
Houttuynia cordata | Aerial parts | Saururaceae | Hyperoside, quercetin, quercitrin, and rutin | 10–50 μg/ml | Reduced RNA production and E-protein | |
Faramea hyacinthina and Faramea truncata | Leaves | Rubiaceae | Antiviral flavanone (2S)-isosakuranetin-7-O-β-d-apiofuranosyl-(1 → 6)-β-d-glucopyranoside (1) | 50 μg/ml | Viral load reduction | [17] |
Justicia adhatoda | Leaves | Acanthaceae | Flavonoids | 1.2Â mg extract | Reduced plaque formation | [126] |
Piper retrofractum | WP | Piperaceae | Alkaloids, amides, prophenylphenols, lignans, | 12–62 µg/ml | Inactivated viral particles | [62] |
Psidium guajava | Leaves | Myrtaceae | Quercetin and catechin | 19.2 µg/ml | DENV-2 replication | [118] |
Phyllanthus sp | WP | Phyllanthaceae | Gallic acid, rutin,geraniin, quercetin glucoside | 15.63–250 µg/ml | NS3, and NS2bNS3 | [67] |
Quersus lucitanica | Seeds | Fagaceae | flavonoids, alkaloids, sterols, polyphenols, tannins, volatile oils | 0.25Â mg/ml | NS1 downregulation | [79] |
Rhizophora apiculata | WP | Rhizophoraceae | Dunnianoside E, ( +)-dihydroquercetin, 2,6- dimethoxy-1,4-benzoquinone | 12.5–100 µg/ml | Inactivated viral particles | [62] |
Spondias mombin | Leaves | Anacardiaceae | Rutin, and quercetin | 362-500 µg/ml | Inhibits viral replication | [109] |
Uncaria tomentosa | Stem, bark | Rubiaceae | Pentacyclic oxindole alkaloids | 100 µg | Reduced viral replication, immunomodulation | [100] |
Annona muricata | leaves | Annonaceae | Alkaloids, phenols, and acetogenins | 0.20–2.5 mg/ml | E-proteins viral replication | |
Catharanthus roseus | Leaves | Apocynaceae | Alkaloids and flavonoids | 0.025–0.13 mg/ml | Enhanced viricidal effects | [1] |
Orthosiphon stamineus | Leaves | Lamiaceae | α-pinene, 1, 8-cineol, borneol, linalool, camphor, eugenol, p-cynene, carvone, d-cdinene | 5 mg/ml | Host-virus interactions |